Different effect of resveratrol to induction of apoptosis depending on the type of human cancer cells

International Journal of Oncology

Volumn 50, Issue 3, 2017, Pages 787-797

  Takashina, Michinori ^a   Inoue, Sayaka ^b   Tomihara, Kei ^b   Tomita, Kengo ^a   Hattori, Kohshi ^c   Zhao, Qing Li ^a   Suzuki, Tokiko ^a   Noguchi, Makoto ^b   Ohashi, Wakana ^a   Hattori, Yuichi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b Oral and Maxillofacial Surgery   (Japan)

^c UNIVERSITY OF TOKYO HOSPITAL   (Japan)

Author keywords

Akt; Apoptosis; Human cancer cells; Ras; Resveratrol

Indexed keywords

ADENOSINE MONOPHOSPHATE ACTIVATED PROTEIN KINASE; PROTEIN BAX; PROTEIN KINASE; PROTEIN KINASE B; RAS PROTEIN; RESVERATROL; SIRTUIN 1; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; BAX PROTEIN, HUMAN; STILBENE DERIVATIVE;

A-549 CELL LINE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CACO-2 CELL LINE; CANCER CELL; CANCER CELL DESTRUCTION; CELL VIABILITY; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HCT 116 CELL LINE; HEP-G2 CELL LINE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MCF-7 CELL LINE; MOLT 4 CELL LINE; PROTEIN TRANSPORT; SW480 CELL LINE; U-937 CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFECTS; METABOLISM; MITOCHONDRION; NEOPLASMS; PATHOLOGY; TUMOR CELL LINE;

A549 CELLS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CACO-2 CELLS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DNA FRAGMENTATION; ENZYME ACTIVATION; HCT116 CELLS; HEP G2 CELLS; HUMANS; MCF-7 CELLS; MITOCHONDRIA; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; SIRTUIN 1; STILBENES;

EID: 85013078029     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2017.3859     Document Type: Article

References (46)

1. Kopp P: Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the French paradox? Eur J Endocrinol 138: 619-620, 1998.
2. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, et al: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220, 1997.
3. Bhat KPL, Kosmeder JW II and Pezzuto JM: Biological effects of resveratrol. Antioxid Redox Signal 3: 1041-1064, 2001.
4. V irgili M and Contestabile A: Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats. Neurosci Lett 281: 123-126, 2000.
5. Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR and Kim AL: Resveratrol: A review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 224: 274-283, 2007.
6. Carter LG, D'Orazio JA and Pearson KJ: Resveratrol and cancer: Focus on in vivo evidence. Endocr Relat Cancer 21: R209-R225, 2014.
7. Clément MV, Hirpara JL, Chawdhury SH and Pervaiz S: Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92: 996-1002, 1998.
8. Tessitore L, Davit A, Sarotto I and Caderni G: Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis 21: 1619-1622, 2000.
9. Ding XZ and Adrian TE: Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Pancreas 25: e71-e76, 2002.
10. Aziz MH, Nihal M, Fu VX, Jarrard DF and Ahmad N: Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins. Mol Cancer Ther 5: 1335-1341, 2006.
11. Tang HY, Shih A, Cao HJ, Davis FB, Davis PJ and Lin HY: Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells. Mol Cancer Ther 5: 2034-2042, 2006.
12. Bai Y, Mao QQ, Qin J, Zheng XY, Wang YB, Yang K, Shen HF and Xie LP: Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo. Cancer Sci 101: 488-493, 2010.
13. Nakagawa H, Kiyozuka Y, Uemura Y, Senzaki H, Shikata N, Hioki K and Tsubura A: Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell stimulator. J Cancer Res Clin Oncol 127: 258-264, 2001.
14. Joe AK, Liu H, Suzui M, Vural ME, Xiao D and Weinstein IB: Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res 8: 893-903, 2002.
15. Shih A, Davis FB, Lin HY and Davis PJ: Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK-And p53-dependent mechanism. J Clin Endocrinol Metab 87: 1223-1232, 2002.
16. Roman V, Billard C, Kern C, Ferry-Dumazet H, Izard JC, Mohammad R, Mossalayi DM and Kolb JP: Analysis of resveratrol-induced apoptosis in human B-cell chronic leukaemia. Br J Haematol 117: 842-851, 2002.
17. Liang YC, Tsai SH, Chen L, Lin-Shiau SY and Lin JK: Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells. Biochem Pharmacol 65: 1053-1060, 2003.
18. Liao PC, Ng LT, Lin LT, Richardson CD, Wang GH and Lin CC: Resveratrol arrests cell cycle and induces apoptosis in human hepatocellular carcinoma Huh-7 cells. J Med Food 13: 1415-1423, 2010.
19. Park JW, Choi YJ, Suh SI, Baek WK, Suh MH, Jin IN, Min DS, Woo JH, Chang JS, Passaniti A, et al: Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity. Carcinogenesis 22: 1633-1639, 2001.
20. Wolter F, Akoglu B, Clausnitzer A and Stein J: Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines. J Nutr 131: 2197-2203, 2001.
21. Gao X, Xu YX, Divine G, Janakiraman N, Chapman RA and Gautam SC: Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes. J Nutr 132: 2076-2081, 2002.
22. Mouria M, Gukovskaya AS, Jung Y, Buechler P, Hines OJ, Reber HA and Pandol SJ: Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome c release and apoptosis. Int J Cancer 98: 761-769, 2002.
23. Mahyar-Roemer M, Katsen A, Mestres P and Roemer K: Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation, mitochondrial proliferation and membrane potential collapse. Int J Cancer 94: 615-622, 2001.
24. Huang C, Ma WY, Goranson A and Dong Z: Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 20: 237-242, 1999.
25. Kuo PL, Chiang LC and Lin CC: Resveratrol-induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells. Life Sci 72: 23-34, 2002.
26. Baur JA: Biochemical effects of SIRT1 activators. Biochim Biophys Acta 1804: 1626-1634, 2010.
27. Sakata K, Kondo T, Mizuno N, Shoji M, Yasui H, Yamamori T, Inanami O, Yokoo H, Yoshimura N and Hattori Y: Roles of ROS and PKC-βII in ionizing radiation-induced eNOS activation in human vascular endothelial cells. Vascul Pharmacol 70: 55-65, 2015.
28. Inoue S, Arai N, Tomihara K, Takashina M, Hattori Y and Noguchi M: Extracellular Ca(2+)-dependent enhancement of cytocidal potency of zoledronic acid in human oral cancer cells. Eur J Pharmacol 761: 44-54, 2015.
29. Taguchi K, Sakata K, Ohashi W, Imaizumi T, Imura J and Hattori Y: Tonic inhibition by G protein-coupled receptor kinase 2 of Akt/endothelial nitric-oxide synthase signaling in human vascular endothelial cells under conditions of hyperglycemia with high insulin levels. J Pharmacol Exp Ther 349: 199-208, 2014.
30. Tomita K, Takashina M, Mizuno N, Sakata K, Hattori K, Imura J, Ohashi W and Hattori Y: Cardiac fibroblasts: Contributory role in septic cardiac dysfunction. J Surg Res 193: 874-887, 2015.
31. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB, et al: Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450: 712-716, 2007.
32. Cardaci S, Filomeni G and Ciriolo MR: Redox implications of AMPK-mediated signal transduction beyond energetic clues. J Cell Sci 125: 2115-2125, 2012.
33. Gillies LA and Kuwana T: Apoptosis regulation at the mitochondrial outer membrane. J Cell Biochem 115: 632-640, 2014.
34. Tsuruta F, Masuyama N and Gotoh Y: The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria. J Biol Chem 277: 14040-14047, 2002.
35. Gardai SJ, Hildeman DA, Frankel SK, Whitlock BB, Frasch SC, Borregaard N, Marrack P, Bratton DL and Henson PM: Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem 279: 21085-21095, 2004.
36. Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR and Tsichlis PN: The protein kinase encoded by the Akt proto-oncogene is a target of the PDGFactivated phosphatidylinositol 3-kinase. Cell 81: 727-736, 1995.
37. Franke TF, Kaplan DR, Cantley LC and Toker A: Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3, 4-bisphosphate. Science 275: 665-668, 1997.
38. Castellano E and Downward J: RAS interaction with PI3K: More than just another effector pathway. Genes Cancer 2: 261-274, 2011.
39. Castellano E and Santos E: Functional specificity of ras isoforms: So similar but so different. Genes Cancer 2: 216-231, 2011.
40. Bradamante S, Barenghi L and Villa A: Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 22: 169-188, 2004.
41. Baur JA and Sinclair DA: Therapeutic potential of resveratrol: The in vivo evidence. Nat Rev Drug Discov 5: 493-506, 2006.
42. Ota H, Tokunaga E, Chang K, Hikasa M, Iijima K, Eto M, Kozaki K, Akishita M, Ouchi Y and Kaneki M: Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells. Oncogene 25: 176-185, 2006.
43. Testa JR and Tsichlis PN: AKT signaling in normal and malignant cells. Oncogene 24: 7391-7393, 2005.
44. Yan J, Roy S, Apolloni A, Lane A and Hancock JF: Ras isoforms vary in their ability to activate Raf-1 and phosphoinositide 3-kinase. J Biol Chem 273: 24052-24056, 1998.
45. V oice JK, Klemke RL, Le A and Jackson JH: Four human ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility. J Biol Chem 274: 17164-17170, 1999.
46. Eisfeld AK, Schwind S, Hoag KW, Walker CJ, Liyanarachchi S, Patel R, Huang X, Markowitz J, Duan W, Otterson GA, et al: NRAS isoforms differentially affect downstream pathways, cell growth, and cell transformation. Proc Natl Acad Sci USA 111: 4179-4184, 2014.